IGT ((VSE:IGT) Blockbuster Anti-Cancer Test Results !!! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IGT ((VSE:IGT) Blockbuster Anti-Cancer Test Results !!!

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: the Chief who wrote (33)	1/13/1998 2:18:00 PM
From: Flea	Read Replies (1) of 94

IGT Pharma Inc - Science Council supports cancer clinical trials IGT Pharma Inc IGT Shares issued 7775915 1998-01-12 close $0.94 Monday Jan 12 1998 Mr Bruce Schmidt reports The Science Council of BC, through its Technology BC program, has recognized IGT Pharma by its involvement in the clinical trials process for the new cancer drug, Anhydrovinblastine (AVLB). The criterion for the selection of the AVLB project was based upon the merits of the concept as an approvable cancer treatment, IGT's ability to successfully manage and finance the process as well as the economic benefits to the province. The Science Council will contribute financially towards the specialized animal testing and chemical analysis that will comprise the basis of an investigational new drug application (IND). The IND submission will be made to both the Canadian Health Protection Branch and the US Food and Drug Administration to allow for phase 1 clinical trials in humans. The first treatment indication selected for AVLB will be non-small cell lung cancer, the form of cancer most commonly associated with smoking.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next